Tracking Covid at the Sanger Institute
Alison Cranage, Science Writer at the Wellcome Sanger Institute
- Credit: Dan Ross / Wellcome Sanger Institute
Scientists across the globe are identifying and tracking new, emerging genetic variants of coronavirus.
This has brought genomic surveillance - the systematic and regular collection and analysis of genetic sequence data - into the spotlight.
Rapid surveillance is also helping public health authorities, and informing the development of next generation Covid-19 vaccines.
The UK has one of the most comprehensive genomic surveillance systems in the world for SARS-CoV-2.
The COVID-19 Genomics UK (COG-UK) consortium, which was started in March 2020, has now sequenced over 300,000 SARS-CoV-2 genomes – just under half of the global total.
You may also want to watch:
The Sanger Institute in Hinxton, with one of the largest genome sequencing facilities in the world, is the central sequencing hub for the consortium and has read 163,000 coronavirus genomes over the past 12 months. Data are rapidly and openly published.
The genome sequence data details the virus’s full genetic code, including any mutations that have occurred as it replicates in our bodies.
- 1 Uttlesford faces 'house building assault', says leader
- 2 Town council welcomes Affinity Water U-turn as supplier announces surcharge
- 3 Essex's Ben Maher takes Tokyo 2020 gold
- 4 Ipswich man to face trial for Braintree car theft and Cheshunt rail incident
- 5 Venue change for Ibiza Anthems Garden Party to Saffron Walden
- 6 In pictures: Fun raises community support cash
- 7 Saffron Walden Town off to winning start with victory at Sawbridgeworth
- 8 Creamfields announces new electronic music festival for Chelmsford, Essex, in 2022
- 9 WaldenTRI come together to produce a strong showing at Bedford Team Relays
- 10 How one business is encouraging pet owners to go plastic free
Viruses mutate all the time, and while most mutations don’t affect their function, some do.
Those that affect the virus’s spike protein, which it uses to bind to and enter human cells, are of particular interest.
Scientists and public health agencies are using the genomic data alongside other information to asses which mutations may affect the virus’s ability to transmit, cause disease or evade the immune response.
Sanger Institute scientists helped identify the B.1.1.7 variant in the UK in late 2020, showing it was more transmissible than previous variants.
The world was swiftly alerted to the threat. Different surveillance projects have picked up other worrying variants as the pandemic continues, and researchers expect 2021 to bring even more.
As people are vaccinated, there is the huge question of how the virus will respond.
There is a possibility that new mutations will enable variants to ‘escape’ vaccines. Sequencing any virus that infects a person who has had the vaccine is a priority for COG-UK.
Early detection of such variants will enable public health authorities, and vaccine manufacturers, to act swiftly.
The genetic changes can also be used as a ‘barcode’ to follow the virus as it moves from person to person.
The data helps to uncover previously hidden routes of transmission, and can be used to rule out or rule in a specific path, or identify a super spreading event.